SurGenTec Gains FDA Clearance for OsteoFlo HydroPutty

SurGenTec marked FDA 510(k) market clearance and the first implantations of OsteoFlo HydroPutty Synthetic Bone Graft.

HydroPutty bone graft technology features a combination of proprietary hydrophilic carriers designed to absorb fluids such as bone marrow aspirate, blood or saline. This formula turns to a putty with ease of handling and a resorption profile optimized for bone growth.

OsteoFlo HydroPutty is supplied in a sterile vial as a dry formulation, accompanied by a mixing spatula. Upon the addition of fluid, the hydrophilic bonds absorb the desired fluid to form a putty. This product can be packed into voids, resists irrigation, and may even be delivered seamlessly through the Graftgun bone graft delivery system.

Source: SurGenTec